Home | Publications | Country place holder
place holder place holder

Country

Pharmaceuticals in Norway


Publication Date   January 2008
Publisher   Datamonitor
Product Type   Strategic Report
Pages   36
ISBN Number   not applicable
Product Code   DAT854
Ask a question about this product?

Price £125.00

approximately: $248 | €159

Summary


Datamonitor's Pharmaceuticals in Norway industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

  • Contains an executive summary and data on value, volume and/or segmentation
  • Provides textual analysis of the industry's recent performance and future prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes a five-year forecast of the industry
  • The leading companies are profiled with supporting key financial metrics
  • Supported by the key macroeconomic and demographic data affecting the market

Highlights

  • Detailed information is included on market size, measured by value and/or volume
  • Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
  • Market shares are covered by manufacturer or brand

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Content


  • Executive Summary
  • Chapter1 Market Overview
    • 1.1
  • Market Definition
    • 1.2 Research
  • Highlights
    • 1.3 Market Analysis
  • Chapter2 Market Value
  • Chapter3 Market Segmentation I
  • Chapter4 Market Segmentation Ii
  • Chapter5 Market Share
  • Chapter6 Five Forces Analysis
    • 6.1 Summary
    • 6.2 Buyer Power
    • 6.3 Supplier Power
    • 6.4 New Entrants
    • 6.5 Substitutes
    • 6.6 Rivalry
  • Chapter7 Leading Companies
    • 7.1 Pfizer A/S
    • 7.2 Glaxosmithkline Plc
    • 7.3 Astrazeneca A/S
    • 7.4 Sanofi-Aventis
  • Chapter8 Market Forecasts
    • 8.1 Market Value Forecast
  • Chapter9 Macroeconomic Indicators
  • Chapter10 Appendix
    • 10.1 Methodology
    • 10.2 Industry Associations
    • 10.3 Related Datamonitor Research
    • List Of Tables
    • Table 1: Norway Pharmaceuticals Market Value: $ Million, 2003-2007
    • Table 2: Norway Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
    • Table 3: Norway Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
    • Table 4: Norway Pharmaceuticals Market Share: % Share, By Value, 2007
    • Table 5: Key Facts: Pfizer A/S
    • Table 6: Key Financials: Pfizer A/S
    • Table 7: Key Facts: Glaxosmithkline Plc
    • Table 8: Key Financials: Glaxosmithkline Plc
    • Table 9: Key Facts: Astrazeneca A/S
    • Table 10: Key Financials: Astrazeneca A/S
    • Table 11: Key Facts: Sanofi-Aventis
    • Table 12: Key Financials: Sanofi-Aventis
    • Table 13: Norway Pharmaceuticals Market Value Forecast: $ Million, 2007-2012
    • Table 14: Norway Size Of Population (Million) , 2003-2007
    • Table 15: Norway Gdp (Constant 2000 Prices, $ Billion), 2003-2007
    • Table 16: Norway Inflation, 2003-2007
    • Table 17: Norway Exchange Rate, 2003